Skip to main content

Stargardt Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Safety and Efficacy of Emixustat in Stargardt Disease

    Sorry, in progress, not accepting new patients

    The purpose of this study is to determine if emixustat hydrochloride reduces the rate of progression of macular atrophy compared to placebo in subjects with Stargardt disease. Funding Source -- FDA OOPD

    San Francisco, California and other locations

Last updated: